Franklin Resources’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,769,944
| Closed | -$150M | – | 1987 |
|
|
2020
Q3 | $150M | Sell |
1,769,944
-675,642
| -28% | -$34.2M | 0.07% | 283 |
|
|
2020
Q2 | $106M | Buy |
2,445,586
+651,500
| +36% | +$19M | 0.05% | 349 |
|
|
2020
Q1 | $24.2M | Buy |
1,794,086
+87,300
| +5% | +$1.47M | 0.02% | 629 |
|
|
2019
Q4 | $36.1M | Buy |
1,706,786
+800,000
| +88% | +$14.1M | 0.02% | 620 |
|
|
2019
Q3 | $12M | Hold |
906,786
| – | – | 0.01% | 850 |
|
|
2019
Q2 | $12.6M | Hold |
906,786
| – | – | 0.01% | 844 |
|
|
2019
Q1 | $17.4M | Buy |
906,786
+130,900
| +17% | +$2.11M | 0.01% | 776 |
|
|
2018
Q4 | $11.1M | Hold |
775,886
| – | – | 0.01% | 851 |
|
|
2018
Q3 | $16.2M | Hold |
775,886
| – | – | 0.01% | 834 |
|
|
2018
Q2 | $18.4M | Buy |
775,886
+86
| +0% | +$1.73K | 0.01% | 795 |
|
|
2018
Q1 | $11.3M | Hold |
775,800
| – | – | 0.01% | 903 |
|
|
2017
Q4 | $12.5M | Buy |
+775,800
| New | +$9.16M | 0.01% | 896 |
|
Franklin Resources's IMMU Position: Q4 2020 in Review
Franklin Resources sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,769,944 shares — an estimated $150M sold.
Franklin Resources first reported a position in IMMU in Q4 2017 and held it in 12 quarters. The position peaked at $150M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Franklin Resources reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Franklin Resources sold 1,769,944 Immunomedics Inc shares in Q4 2020, an estimated $150M.
- Franklin Resources first reported a position in Immunomedics Inc in Q4 2017 and held it in 12 quarters.
- Franklin Resources's Immunomedics Inc position peaked at $150M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Franklin Resources's 13F filing for Q4 2020, filed 10 Feb 2021.